DE3856597D1 - Testverfahren mit verbesserten Chemilumineszierenden Estern, Thioestern und Amiden - Google Patents

Testverfahren mit verbesserten Chemilumineszierenden Estern, Thioestern und Amiden

Info

Publication number
DE3856597D1
DE3856597D1 DE3856597T DE3856597T DE3856597D1 DE 3856597 D1 DE3856597 D1 DE 3856597D1 DE 3856597 T DE3856597 T DE 3856597T DE 3856597 T DE3856597 T DE 3856597T DE 3856597 D1 DE3856597 D1 DE 3856597D1
Authority
DE
Germany
Prior art keywords
ring
linkage
ring system
substituent groups
heterocyclic ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3856597T
Other languages
English (en)
Inventor
Frank Mccapra
Iraj Beheshti
Russell C Hart
Harlen Koelling
Ashokkumar Patel
Kastooriranganath Ramakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nichols Institute Diagnostics
Original Assignee
Nichols Institute Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26837818&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3856597(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nichols Institute Diagnostics filed Critical Nichols Institute Diagnostics
Anticipated expiration legal-status Critical
Publication of DE3856597D1 publication Critical patent/DE3856597D1/de
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE3856597T 1987-12-31 1988-12-30 Testverfahren mit verbesserten Chemilumineszierenden Estern, Thioestern und Amiden Expired - Lifetime DE3856597D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14004087A 1987-12-31 1987-12-31
US29184388A 1988-12-29 1988-12-29

Publications (1)

Publication Number Publication Date
DE3856597D1 true DE3856597D1 (de) 2009-04-30

Family

ID=26837818

Family Applications (3)

Application Number Title Priority Date Filing Date
DE883891212T Withdrawn DE3891212T1 (de) 1987-12-31 1988-12-30 Assays unter verwendung von verbesserten chemilumineszierenden estern, thioestern und amiden
DE3856358T Expired - Lifetime DE3856358T3 (de) 1987-12-31 1988-12-30 Für Tests verwendbare chemilumineszierende Ester, Thioester und Amide
DE3856597T Expired - Lifetime DE3856597D1 (de) 1987-12-31 1988-12-30 Testverfahren mit verbesserten Chemilumineszierenden Estern, Thioestern und Amiden

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE883891212T Withdrawn DE3891212T1 (de) 1987-12-31 1988-12-30 Assays unter verwendung von verbesserten chemilumineszierenden estern, thioestern und amiden
DE3856358T Expired - Lifetime DE3856358T3 (de) 1987-12-31 1988-12-30 Für Tests verwendbare chemilumineszierende Ester, Thioester und Amide

Country Status (14)

Country Link
EP (2) EP0322926B2 (de)
JP (1) JP3172522B2 (de)
KR (1) KR900700888A (de)
AT (2) ATE425970T1 (de)
AU (1) AU635890B2 (de)
CA (1) CA1341613C (de)
DE (3) DE3891212T1 (de)
ES (1) ES2134185T5 (de)
GB (4) GB2232995B (de)
GR (1) GR3031647T3 (de)
IE (1) IE61614B1 (de)
IL (1) IL88848A (de)
NZ (1) NZ227506A (de)
WO (1) WO1989006231A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918192A (en) * 1986-10-06 1990-04-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
ATE111083T1 (de) * 1986-10-22 1994-09-15 Abbott Lab Chemilumineszierende acridinium- und phenantridiniumsalze.
US4950613A (en) * 1988-02-26 1990-08-21 Gen-Probe Incorporated Proteted chemiluminescent labels
JP2681061B2 (ja) * 1988-06-08 1997-11-19 ロンドン・ダイアグノスティック・インコーポレーテッド 検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ
US5227489A (en) * 1988-08-01 1993-07-13 Ciba Corning Diagnostics Corp. Stable hydrophilic acridinium esters suitable for liposome encapsulation
US5656426A (en) * 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
US5663074A (en) * 1988-09-26 1997-09-02 Chiron Diagnostics Corporation Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof
CA1339491C (en) * 1988-09-26 1997-10-07 Say-Jong Law Nucleophilic polysubstituted aryl acridinium ester and uses thereof
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
WO1994002486A1 (en) * 1992-07-20 1994-02-03 Syntex (U.S.A.) Inc. Novel chemiluminescent compounds and methods of use
US6002000A (en) * 1992-07-20 1999-12-14 Dade Behring Marburg Gmbh Chemiluminescent compounds and methods of use
WO1994003812A1 (en) * 1992-07-31 1994-02-17 Syntex (U.S.A.) Inc. Photoactivatable chemiluminescent matrices
JP3584379B2 (ja) * 1993-02-04 2004-11-04 持田製薬株式会社 アクリジニウム化合物およびアクリジニウム化合物複合体
US5395752A (en) * 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
US5491072A (en) * 1993-05-17 1996-02-13 Lumigen, Inc. N-alkylacridan carboxyl derivatives useful for chemiluminescent detection
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0761652A1 (de) * 1995-08-01 1997-03-12 Mochida Pharmaceutical Co., Ltd. Acridiniumverbindung mit mehreren lumineszierenden Gruppen und Bindungsgruppen und Konjugate derselben
EP0915851B1 (de) * 1996-07-16 2002-03-20 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Dibenzodihydropyridincarbonsäureester und ihre anwendung in chemolumineszenz-untersuchungsverfahren
US6165800A (en) * 1997-05-30 2000-12-26 Bayer Corporation Chemiluminescent energy transfer conjugates and their uses as labels in binding assays
ATE307116T1 (de) * 1997-08-21 2005-11-15 Maine Medical Ct Auf peroxiden basierender chemilumineszenztest und chemilumineszente verbindungen die in diesem benutzt werden
US6723851B2 (en) * 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461877A (en) * 1974-02-12 1977-01-19 Wellcome Found Assay method utilizing chemiluminescence
GB2112779B (en) * 1981-12-11 1986-10-15 Welsh Nat School Med Aryl acridinium esters as luminescent labelling materials
US4687747A (en) * 1984-07-02 1987-08-18 Mallinckrodt, Inc. Phenanthridinium ester as a labelling compound in luminometric immunoassay
JPS6261969A (ja) * 1985-09-06 1987-03-18 アモコ・コーポレーション アクリジニウムエステルの合成法
DE3628573C2 (de) * 1986-08-22 1994-10-13 Hoechst Ag Chemilumineszierende Acridinderivate, Verfahren zu deren Herstellung und ihre Verwendung in Lumineszenzimmunoassays
US4745181A (en) * 1986-10-06 1988-05-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
ATE111083T1 (de) * 1986-10-22 1994-09-15 Abbott Lab Chemilumineszierende acridinium- und phenantridiniumsalze.
KR960002561B1 (ko) * 1987-09-21 1996-02-22 젠-프로우브 인코퍼레이티드 균질보호분석법
NL8703075A (nl) 1987-12-18 1989-07-17 Nederlanden Staat Acridiniumverbindingen als chemiluminescentie-merkstof.

Also Published As

Publication number Publication date
GB2252162A (en) 1992-07-29
IE61614B1 (en) 1994-11-16
AU2927089A (en) 1989-08-01
ES2134185T3 (es) 1999-10-01
ATE183311T1 (de) 1999-08-15
EP0916658A1 (de) 1999-05-19
DE3856358T3 (de) 2004-12-30
IE883895L (en) 1989-06-30
GB2232995B (en) 1992-10-14
GB2232995A (en) 1991-01-02
GB2251942A (en) 1992-07-22
KR900700888A (ko) 1990-08-17
DE3891212T1 (de) 1991-01-10
GB9203180D0 (en) 1992-04-01
IL88848A0 (en) 1989-07-31
GB9203179D0 (en) 1992-04-01
ATE425970T1 (de) 2009-04-15
EP0322926A3 (de) 1991-03-20
ES2134185T5 (es) 2004-11-01
DE3856358T2 (de) 2000-04-20
EP0322926B1 (de) 1999-08-11
EP0916658B1 (de) 2009-03-18
GB9203181D0 (en) 1992-04-01
AU635890B2 (en) 1993-04-08
WO1989006231A1 (en) 1989-07-13
JPH03501772A (ja) 1991-04-18
GR3031647T3 (en) 2000-02-29
GB2252161A (en) 1992-07-29
GB9014479D0 (en) 1990-10-03
CA1341613C (en) 2011-05-10
DE3856358D1 (de) 1999-09-16
JP3172522B2 (ja) 2001-06-04
EP0322926A2 (de) 1989-07-05
NZ227506A (en) 1992-06-25
IL88848A (en) 1994-02-27
EP0322926B2 (de) 2004-03-31

Similar Documents

Publication Publication Date Title
DE3856597D1 (de) Testverfahren mit verbesserten Chemilumineszierenden Estern, Thioestern und Amiden
ATE177743T1 (de) Langkettiger carbonsäureimidester
DK0526642T3 (da) Triterpenderivat
GB1490603A (en) Glycerides with anti-inflammatory properties
ES8304120A1 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
DE3777325D1 (de) 2-amino-4-phosphonyl-buttersaeurederivate und herstellung von 2-amino-4-phosphinyl-butter-saeuren.
PT88463A (pt) Process for the preparation of macrolide compounds and of compositions containing them
DK0381628T3 (da) Glycocyamidinderivater
FR2336409A1 (fr) Melanges d'esters phosphoreux utilisables comme stabilisants de matieres organiques
FI890929A (fi) Foerfarande foer framstaellning av ftalazinaettiksyraesterderivat och ny mellanprodukt.
ATE967T1 (de) Verfahren zur herstellung von xanthonderivaten.
IE37905B1 (en) A process for producing 7-acylamino-3-methyl-3-cephem-4-carboxylic acids
SE7900889L (sv) Sett att framstella xantonderivat
TH22461A (th) อนุพันธ์พิเพอร์คิล-ไทรอาซีน ชนิดใหม่และการใช้สารทำให้โพทำให้โพลิเมอร์เสถียร
TH22461EX (th) อนุพันธ์พิเพอร์คิล-ไทรอาซีน ชนิดใหม่และการใช้สารทำให้โพทำให้โพลิเมอร์เสถียร